Pharmaceutical giant Eli Lilly and the Department of Health and Human Services faced intense scrutiny from a federal appeals court as they advanced starkly contrasting positions on a government drug discount program that could shape access to drugs for low-income Americans.
Both Eli Lilly and the HHS allege federal law overseeing the program is straightforward yet come “to completely opposite conclusions” on what it requires of drugmakers providing discounted products, Judge Frank Easterbrook of the US Court of Appeals for the Seventh Circuit said in a Monday hearing
The hearing was before a three-judge panel and is part of a ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.